Nektar Therapeutics Corporation
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Total Funding:
1200000000
Acquisitions Number:
2.0
Headquarters:
San Carlos, California, United States
Funding Status:
IPO
Employee Number:
501-1000
Estimated Revenue:
$50M to $100M
Last Funding Type:
Post-IPO Equity
Number Of Exists:
1
Technology:
Biotechnology, Chemical, Health Care, Therapeutics
Founded Date:
1990
Industry:
Pharma